Breeze Holdings Acquisition CORP 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
Breeze Holdings Acquisition Corp. reported a net loss of $5.58 million for the first half of 2025, while progressing towards its business combination with YD Biopharma and securing $13.2 million in PIPE financing.
Breeze Holdings Acquisition Corp. reports a significant net loss and negative working capital, raising substantial doubt about its ability to continue as a going concern, despite securing an extension for its business combination deadline and identifying a new merger target, YD Biopharma Limited.
Breeze Holdings Acquisition Corp. reported a net income of $2.19 million for the third quarter of 2024, while facing ongoing challenges related to its business combination and going concern status.
Breeze Holdings Acquisition Corp. reported a net income of $17.1 million for the three months ended June 30, 2024, primarily driven by changes in the fair value of warrant liabilities, while facing ongoing challenges in completing a business combination.
Breeze Holdings Acquisition Corp. reported a significant net loss for the first quarter of 2024, primarily due to changes in the fair value of warrant liabilities, while progressing towards its planned merger with True Velocity.
Breeze Holdings Acquisition Corp. has filed an amendment to its quarterly report to correct an omission in the certification of its principal executive and financial officer.
Breeze Holdings Acquisition Corp. has filed an amendment to its quarterly report to correct an omission in the certification of its principal executive and financial officer.
Breeze Holdings Acquisition Corp. filed an amendment to its quarterly report to correct an omission in the officer's certification regarding internal controls over financial reporting.